# OnCo record nouscom (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/nouscom/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "nouscom" ;
  schema:name "Nouscom"@en ;
  schema:description "Nouscom is developing Nous-209, an off-the-shelf viral-vector vaccine encoding 209 shared frameshift neoantigens to intercept cancer in Lynch syndrome carriers."@en ;
  schema:url <https://onco.cc/companies/nouscom/>, <https://nouscom.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.nature.com/articles/s41591-025-04182-9> ;
  schema:addressCountry "CH" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/shared-antigen-vaccine/>, <https://onco.cc/technologies/chemoprevention/> ;
  onco:terms <https://onco.cc/terms/msi/>, <https://onco.cc/terms/neoantigen/> ;
  onco:trials <https://onco.cc/trials/nct04041310/> .